Upon
determination of the optimal conditions of use of a novel compound, the
next challenge is to facilitate and strengthen its progress through the
drug development process towards the clinic. This translational
research is based on the discovery of molecular biomarkers of the
efficacy of treatment.
Pharmaco-imaging
Pharmaco-imaging
is the marriage between imaging and pharmacology that provides
additional information that could not otherwise be obtained using
traditional techniques. It allows for a more precise, faster and direct
translation of data from a preclinical to clinical context. The
development of techniques useful for pharmaco-imaging are fully
integrated in Oncodesign’s R&D axes.
PK/PD relationship
The
aim of this phase is to optimize the pharmacokinetic and
pharmacodynamic parameters for the clinical development of an
anticancer drug, which may help reduce the risks and costs of
subsequent human trials.
Home
Back
Top